Home > Insider Trading > Filing (0001104659-21-125932)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1773427	Springworks Therapeutics Inc.	SWTX	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1787013	Mary L. Smith	C/O Springworks Therapeutics, Inc., 100 Washington Blvd. Stamford CT 06902	Chief Development Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-10-13	10,000	$2.30	177,511	No	4	M	Direct
Common Stock	Disposition	2021-10-13	10,000	$55.97	167,511	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-10-13	10,000	$0.00	10,000	$2.30

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
84,296		2029-04-22	No	4	M	Direct

Footnotes

The stock option exercises and sale transactions reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.95 to $56.99, inclusive.
Includes 27,304 restricted stock awards which are subject to forfeiture until they vest.
This option began to vest and become exercisable in 48 equal monthly installments beginning on April 22, 2019.